Medical Communications
Swing Therapeutics receives FDA authorisation for digital therapeutic for fibromyalgia
May 22, 2023 Medical Communications CBT, Devices, FDA, Swing Therapeutics, fibromyalgia
Krystal Biotech secures FDA approval for redosable topical gene therapy
May 22, 2023 Medical Communications FDA, Krystal Biotech, Paediatrics, dystrophic epidermolysis bullosa, gene therapy
Schott Pharma announces pre-filled polymer syringes for deep-cold medication
May 19, 2023 Medical Communications Devices, Schott Pharma, deep cold medication, syringe
NHS given guidance on offering genetic testing to stroke patients
May 19, 2023 Medical Communications NHS, Neurology, blood clot, genetic testing, stroke
NICE recommends Kapruvia for treatment of moderate-to-severe CKD-associated pruritus
May 18, 2023 Medical Communications Kapruvia, NICE, Nephrology, chronic kidney disease, pruritus
US appeals court hears arguments in abortion pill case
May 18, 2023 Medical Communications Obstetrics & Gynaecology, abortion, medication abortion, mifepristone, reproduction
NICE recommends nine digital treatment options for depression and anxiety
May 17, 2023 Medical Communications NICE, Neurology, anxiety, depression, digital health, mental health
RadioMedix and Orano Med complete patient enrolment for neuroendocrine cancer trial
May 16, 2023 Medical Communications Oncology, Orano Med, RadioMedix, neuroendocrine cancer, oncology
NICE recommends Hepcludex for NHS use to treat aggressive form of viral hepatitis
May 15, 2023 Medical Communications NHS, NICE, Virology, hepatitis
FDA approves new nonhormonal medication for menopause hot flashes
May 15, 2023 Medical Communications FDA, HRT, Veozah, hot flashes, menopause
FDA relaxes blood donation regulations for MSM
May 12, 2023 Medical Communications FDA, HIV, HIV/AIDS, blood donation
Bellerophon Therapeutics completes phase 3 study for fibrotic interstitial lung disease drug
May 12, 2023 Medical Communications Bellerophon Therapeutics, Cardiology, clinical trial, lung disease
FDA advisory committee votes in favour of OTC contraceptive pill
May 11, 2023 Medical Communications Contraception, FDA, OTC, Perrigo, contraception
Otsuka and Lundbeck gain FDA approval for supplemental New Drug Application for dementia drug
May 11, 2023 Medical Communications FDA, Lundbeck, Neurology, Otsuka Pharmaceuticals, alzheimer's disease, dementia
AstraZeneca’s Ultomiris approved in EU for adults firm NMOSD
May 11, 2023 Medical Communications AstraZeneca, NMOSD, Neurology, Ultomiris, neurology
Latest content
